Automated ventricular segmentation and shunt failure detection using convolutional neural networksSCIENTIFIC REPORTSIF3.92024-09-272OAAI
Immunotherapy approaches for the treatment of diffuse midline gliomasONCOIMMUNOLOGYIF6.32022-09-2623OA
Standard clinical approaches and emerging modalities for glioblastoma imagingNEURO-ONCOLOGY ADVANCESIF4.12022-05-2623OAAI
Targeting oncometabolism to maximize immunotherapy in malignant brain tumorsONCOGENEIF7.32022-04-169OAAI
Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survivalNEURO-ONCOLOGYIF13.42018-10-2242OAAI
Deep brain stimulation for seizure control in drug-resistant epilepsy深部脑刺激控制耐药性癫痫发作NEUROSURGICAL FOCUSIF32018-08-0170OAAI
Tumor treating fields (TTFields) decrease proliferation of patient-derived lung cancer brain metastasis cells in vitroCANCER RESEARCHIF16.62018-07-010PRE
In vitro Tumor Treating Fields (TTFields) alter proliferation and morphology of patient-derived high-grade meningioma cell linesCANCER RESEARCHIF16.62018-07-011PRE
Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumorsJOURNAL OF NEURO-ONCOLOGYIF3.12018-04-1744OAAI
Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studiesJOURNAL OF NEUROSURGERYIF3.62018-02-018OAAI
Prognostic Molecular and Imaging Biomarkers in Primary GlioblastomaCLINICAL NUCLEAR MEDICINEIF9.62017-05-0123OAAI
Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-L-Tryptophan and α-11C-Methyl-L-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor XenograftsJOURNAL OF NUCLEAR MEDICINEIF9.12016-10-2028OAAI
Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1JOURNAL OF TRANSLATIONAL MEDICINEIF7.52015-07-1517OAAI
Structures of the Class D Carbapenemases OXA-23 and OXA-146: Mechanistic Basis of Activity against Carbapenems, Extended-Spectrum Cephalosporins, and AztreonamANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52013-10-0181OAAI